67 related articles for article (PubMed ID: 8275827)
1. [HATP chemotherapy combined with Chinese traditional medications in treating acute promyelocytic leukemia].
Guo AX; Huang SL; Wang QE
Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):470-2. PubMed ID: 8275827
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute promyelocytic leukemia with all-trans retinoic acid. A five-year experience.
Sun GL; Ouyang RR; Chen SJ; Gu YZ; Huang LA; Lu JX; Wang ZY
Chin Med J (Engl); 1993 Oct; 106(10):743-8. PubMed ID: 8033606
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the therapeutic efficacy and prognostic factors of intensive chemotherapy in 91 patients with acute nonlymphoblastic leukemia].
Bian SG; Hao YS; Wang ZC
Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):22-5, 60. PubMed ID: 2401166
[TBL] [Abstract][Full Text] [Related]
4. Management of acute promyelocytic leukemia relapse in the ATRA era.
Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
[TBL] [Abstract][Full Text] [Related]
5. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent promyelocytic leukemia with a combination regimen utilizing amsacrine, cytosine arabinoside and 6-thioguanine (AAT).
Avvisati G; Petti MC; Petrucci MT; Falconi E; Tirindelli MC; Mandelli F
Haematologica; 1989; 74(3):279-82. PubMed ID: 2511097
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
Bassan R; Battista R; Viero P; d'Emilio A; Buelli M; Montaldi A; Rambaldi A; Tremul L; Dini E; Barbui T
Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
[TBL] [Abstract][Full Text] [Related]
8. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute promyelocytic leukemia: a single institution experience.
Ruiz-Argüelles GJ; Morales-Toquero A; Gómez-Rangel JD; López-Martínez B; Ruiz-Delgado GJ; Reyes-Núñez V
Rev Invest Clin; 2005; 57(3):415-9. PubMed ID: 16187701
[TBL] [Abstract][Full Text] [Related]
10. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ
J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China.
Wang ZY; Sun GL; Lu JX; Gu LJ; Huang ME; Chen SR
Nouv Rev Fr Hematol (1978); 1990; 32(1):34-6. PubMed ID: 2349080
[TBL] [Abstract][Full Text] [Related]
12. [Combination treatment of acute non-lymphocytic leukemia with HOAP and AA--preliminary report of 14 cases].
Zhang GZ
Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):52-4. PubMed ID: 1889339
[TBL] [Abstract][Full Text] [Related]
13. [Effect of post-remission therapy mainly with compound huangdai tablet on long-term survival of patients with acute promyelocytic leukemia].
Xiang Y; Chang XH; Cheng YB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1253-6. PubMed ID: 21302484
[TBL] [Abstract][Full Text] [Related]
14. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
Eardley AM; Heller G; Warrell RP
Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
17. [HOAP/HOAGP in the treatment of acute non-lymphocytic leukemia: an analysis of 68 cases].
Shan YD
Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):590-2. PubMed ID: 3938671
[No Abstract] [Full Text] [Related]
18. Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.
Head DR; Kopecky KJ; Willman C; Appelbaum FR
Leukemia; 1994; 8 Suppl 2():S38-41. PubMed ID: 7815835
[TBL] [Abstract][Full Text] [Related]
19. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
